2025
SJR Q2
JCR Q3 · 2,6
OA
ESCI
Journal detail
JMIR Cancer
- Publisher
- JMIR Publications Inc.
- Country
- Canada · Northern America
- Type
- journal
- ISSN
-
23691999
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,798
- Quartile Q2
- H-Index 31
- Cites/doc 3,12
- Docs (3y) 201
- Cites (3y) 685
Clarivate
Web of Science · JCR · 2025
- JCR Q Q3
- JIF 2,6
- 5Y JIF 3,7
- JCI 0,56
WoS indexes
- ESCI
Subject classification
Categories (SJR)
- Cancer Research Q3
- Oncology Q2
Areas
- Biochemistry, Genetics and Molecular Biology
- Medicine
WoS categories
- Oncology
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q3 | 0,798 | 2,6 | 3,7 | 0,56 | Q3 | 31 |
| 2024 | Q2 | Q3 | 1,025 | 2,7 | 3,3 | 0,64 | Q3 | 28 |
| 2023 | Q2 | Q2 | 0,79 | 3,3 | 3,1 | 0,66 | Q2 | 28 |
| 2022 | Q2 | — | 0,724 | 2,8 | 2,9 | 0,59 | Q3 | 28 |
| 2021 | Q3 | — | 0,661 | — | — | 0,52 | Q3 | 28 |
| 2020 | — | — | — | — | — | 0,53 | Q3 | 28 |
| 2019 | — | — | — | — | — | — | — | 28 |
| 2017 | — | — | — | — | — | — | — | 28 |
| 2016 | — | — | — | — | — | — | — | 28 |
| 2015 | — | — | — | — | — | — | — | 28 |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | ONCOLOGY | ESCI | Q3 | Q3 | 196/333 |
| 2024 | ONCOLOGY | ESCI | Q3 | Q3 | 171/328 |
| 2023 | ONCOLOGY | ESCI | Q2 | Q2 | 118/322 |
| 2022 | ONCOLOGY | ESCI | — | Q3 | — |
| 2021 | ONCOLOGY | ESCI | — | Q3 | — |
| 2020 | ONCOLOGY | ESCI | — | Q3 | — |